Different Associations of Plasma Biomarkers in Alzheimer’s Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Cognitive and cerebrovascular diseases are common in the elderly, but differences in the plasma levels and associations of plasma biomarkers in these diseases remain elusive. Methods The present study investigated differences in plasma fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)], adiponectin, reptin, plasma markers of inflammation [high-sensitivity C-reactive protein (hsCRP) and serum amyloid A (serum AA)], and plasma lipids [high-density lipoprotein and low-density lipoprotein (LDL)] in patients with Alzheimer’s disease (AD) (n=266), mild cognitive impairment (MCI) (n=44), vascular dementia (VaD) (n=33), and ischemic stroke (IS) (n=200) in comparison to normal controls (n=130). Results The serological data showed that lower EPA and DHA levels and higher reptin and LDL levels were associated with AD and IS, the reptin/adiponectin ratio was strongly associated with IS, the hsCRP level was more strongly associated with VaD and IS, and the serum AA level was associated with all three cognitive diseases and IS. Conclusions This is the first report of differences in the expression levels of plasma biomarkers and peripheral arterial tonometry among AD, MCI, VaD, and IS patients and normal controls. These different associations indicate that diverse pathological mechanisms underlie these diseases
Abstract
Background and Purpose Cognitive and cerebrovascular diseases are common in the elderly, but differences in the plasma levels and associations of plasma biomarkers in these diseases remain elusive. Methods The present study investigated differences in plasma fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)], adiponectin, reptin, plasma markers of inflammation [high-sensitivity C-reactive protein (hsCRP) and serum amyloid A (serum AA)], and plasma lipids [high-density lipoprotein and low-density lipoprotein (LDL)] in patients with Alzheimer’s disease (AD) (n=266), mild cognitive impairment (MCI) (n=44), vascular dementia (VaD) (n=33), and ischemic stroke (IS) (n=200) in comparison to normal controls (n=130). Results The serological data showed that lower EPA and DHA levels and higher reptin and LDL levels were associated with AD and IS, the reptin/adiponectin ratio was strongly associated with IS, the hsCRP level was more strongly associated with VaD and IS, and the serum AA level was associated with all three cognitive diseases and IS. Conclusions This is the first report of differences in the expression levels of plasma biomarkers and peripheral arterial tonometry among AD, MCI, VaD, and IS patients and normal controls. These different associations indicate that diverse pathological mechanisms underlie these diseases
참고문헌 (30)
- Kraal JJ, "Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@ Home study", BMC Cardiovasc Disord, 13, pp.82~ (2013)[DOI]
- Hishikawa N, "Characteristic features of cognitive, affective and daily living functions of late-elderly dementia", Geriatr Gerontol Int, 16, pp.458~465 (2016)[DOI]
- Rizzi L, "Global epidemiology of dementia: Alzheimer's and vascular types", Biomed Res Int, 2014, pp.908915~ (2014)
- Lopez OL, "Mild cognitive impairment", Continuum (Minneap Minn), 19(2 Dementia), pp.411~424 (2013)
- Takashima N, "Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese-Shiga Stroke Registry", Circ J, 81, pp.1636~1646 (2017)[DOI]
- Kume A, "Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study", Nutr Metab (Lond), 10, pp.41~ (2013)[DOI]
- Yurko-Mauro K, "Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline", Curr Alzheimer Res, 7, pp.190~196 (2010)[DOI]
- Diop SB, "Reptin and Pontin function antagonistically with PcG and TrxG complexes to mediate Hox gene control", EMBO Rep, 9, pp.260~266 (2008)[DOI]
- Stojanovic S, "The significance of adiponectin as a biomarker in metabolic syndrome and", or coronary artery disease, 2015, pp.72, 779~784
- Kliper E, "Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume", Stroke, 44, pp.1433~1435 (2013)[DOI]
- Urieli-Shoval S, "Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states", Curr Opin Hematol, 7, pp.64~69 (2000)[DOI]
- Hottman DA, "HDL and cognition in neurodegenerative disorders", Neurobiol Dis, 72, pp.22~36 (2014)[DOI]
- Stampfer MJ, "Cardiovascular disease and Alzheimer's disease: common links", J Intern Med, 260, pp.211~223 (2006)[DOI]
- McKhann GM, "The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease", Alzheimers Dement, 7, pp.263~269 (2011)[DOI]
- DeLaPaz RL, "ACR Appropriateness Criteria<TEX>$^{(R)}$<", TEX> on cerebrovascular disease, 2011, pp.8, 532~538
- Simopoulos AP, "An increase in the omega-6", omega-3 fatty acid ratio increases the risk for obesity, 2016, pp.8, 128~
- Kim M, "Erythrocyte <TEX>${\alpha}$<", TEX>-linolenic acid is associated with the risk for mild dementia in Korean elderly, 2010, pp.30, 756~761
- Yurko-Mauro K, "Beneficial effects of docosahexaenoic acid on cognition in agerelated cognitive decline", Alzheimers Dement, 6, pp.456~464 (2010)[DOI]
- Grigoletto A, "The multifaceted proteins Reptin and Pontin as major players in cancer", Biochim Biophys Acta, 1815, pp.147~157 (2011)
- Song J, "Association between risk factors for vascular dementia and adiponectin", Biomed Res Int, 2014, pp.261672~ (2014)
- Sener U, "Is adiponectin a risk factor for transient ischaemic attacks?", Endokrynol Pol, 66, pp.214~218 (2015)[DOI]
- Khemka VK, "Altered serum levels of adipokines and insulin in probable Alzheimer's disease", J Alzheimers Dis, 41, pp.525~533 (2014)[DOI]
- Shimabukuro M, "Hypoadiponectinemia is closely linked to endothelial dysfunction in man", J Clin Endocrinol Metab, 88, pp.3236~3240 (2003)[DOI]
- Sasaki M, "Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction", Metabolism, 59, pp.527~532 (2010)[DOI]
- Chen MP, "Hypoadiponectinemia is associated with ischemic cerebrovascular disease", Arterioscler Thromb Vasc Biol, 25, pp.821~826 (2005)[DOI]
- Hu SL, "Cognitive changes during prolonged stay at high altitude and its correlation with C-reactive protein", PLoS One, 11, pp.e0146290~ (2016)[DOI]
- Dullaart RP, "Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene", Arterioscler Thromb Vasc Biol, 30, pp.1502~1503 (2010)[DOI]
- Yokoyama S, "Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors", Nutrients, 7, pp.2359~2381 (2015)[DOI]
- Zanchetti A, "Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence", J Hypertens, 32, pp.1741~1750 (2014)[DOI]
- Lim SL, "Vascular health indices and cognitive domain function: Singapore longitudinal ageing studies", J Alzheimers Dis, 50, pp.27~40 (2016)